• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Cognitive dysfunction in MS: Update from EAN

June 10, 2020  

SPMS: new data and developments

June 2, 2020  

Sun exposure and MS: effects beyond vitamin D

May 26, 2020  

Treatment optimization in MS – new Canadian recommendations

May 15, 2020  

Siponimod – new data in SPMS

April 23, 2020  

FDA approves ozanimod in MS

April 16, 2020  

MS and coronavirus have a long history

April 9, 2020  

MS 2020 – the view from a decade ago

March 18, 2020  

Natalizumab use in late pregnancy

February 19, 2020  

New drug approvals in 2020

February 5, 2020  
Previous
20
21
22
23
24
Next

Browse by Topic

  • MSToronto2026 (6)
  • MS (450)
  • CLINICAL CASES (22)
  • EAN 2026 (2)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • MSToronto 2026 Highlights – Thursday, October 22, 2026 posted on October 22, 2026
  • MSToronto 2026 Highlights – Friday, October 23, 2026 posted on October 23, 2026
  • MSToronto 2026 Highlights – Wednesday, October 21, 2026 posted on October 21, 2026
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions